Analysts Set Alto Neuroscience, Inc. (NYSE:ANRO) PT at $15.40
Alto Neuroscience, Inc. (NYSE:ANRO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price objective among […]
Alto Neuroscience, Inc. (NYSE:ANRO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price objective among […]
